d) Company A says that it has provided 138 patents, of which 45 were successful, giving a success rate of 32.6%. The corresponding figure for Company B is 30.7%. How would Company B respond to this claim? O A. Company B would respond that Company A's overall success rate is greater because Company A has submitted a higher volume of patent requests. O B. Company B would respond that Company A's overall success rate is greater because Company A's patent requests are subjected to a more lenient approval process. O C. Company B would respond that Company A's overall success rate is greater because it focuses on anti-inflammatory drug patents whose overall success rate is higher than the success rate for other drug patents. O D. Company B would respond that Company A's overall success rate is greater because Company B has yet to submit a new batch of patent requests for which it expects a high success rate for all drug types. e) (i) If the pharmaceutical company wants to buy a patent, which biotechnology company is better for genetic disease drugs? The pharmaceutical should buy the patent from Company because it has a success rate with genetic disease drugs of which is greater than the other company. (Deund
d) Company A says that it has provided 138 patents, of which 45 were successful, giving a success rate of 32.6%. The corresponding figure for Company B is 30.7%. How would Company B respond to this claim? O A. Company B would respond that Company A's overall success rate is greater because Company A has submitted a higher volume of patent requests. O B. Company B would respond that Company A's overall success rate is greater because Company A's patent requests are subjected to a more lenient approval process. O C. Company B would respond that Company A's overall success rate is greater because it focuses on anti-inflammatory drug patents whose overall success rate is higher than the success rate for other drug patents. O D. Company B would respond that Company A's overall success rate is greater because Company B has yet to submit a new batch of patent requests for which it expects a high success rate for all drug types. e) (i) If the pharmaceutical company wants to buy a patent, which biotechnology company is better for genetic disease drugs? The pharmaceutical should buy the patent from Company because it has a success rate with genetic disease drugs of which is greater than the other company. (Deund
Chapter6: Systems Of Equations And Inequalities
Section: Chapter Questions
Problem 17PS: Cholesterol Cholesterol in human blood is necessary, but too much can lead to health problems. There...
Related questions
Question
8
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
Step by step
Solved in 2 steps
Recommended textbooks for you
Linear Algebra: A Modern Introduction
Algebra
ISBN:
9781285463247
Author:
David Poole
Publisher:
Cengage Learning
Glencoe Algebra 1, Student Edition, 9780079039897…
Algebra
ISBN:
9780079039897
Author:
Carter
Publisher:
McGraw Hill
Linear Algebra: A Modern Introduction
Algebra
ISBN:
9781285463247
Author:
David Poole
Publisher:
Cengage Learning
Glencoe Algebra 1, Student Edition, 9780079039897…
Algebra
ISBN:
9780079039897
Author:
Carter
Publisher:
McGraw Hill
College Algebra
Algebra
ISBN:
9781305115545
Author:
James Stewart, Lothar Redlin, Saleem Watson
Publisher:
Cengage Learning
Algebra and Trigonometry (MindTap Course List)
Algebra
ISBN:
9781305071742
Author:
James Stewart, Lothar Redlin, Saleem Watson
Publisher:
Cengage Learning